Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies
- PMID: 11751441
Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies
Abstract
The aim of this study was to investigate the association of NAT2 gene polymorphism with bladder cancer using the data derived from the International Project on Genetic Susceptibility to Environmental Carcinogens. Four case control studies conducted in four European countries, plus two case series, one from England and one from Germany, for a total of 1530 cases and 731 controls (all Caucasian) were included. The interaction between NAT2 and bladder cancer considering smoking habits and occupational exposure was studied. There was a significant association between NAT2 and bladder cancer (odds ratio: 1.42, 95% confidence interval: 1.14-1.77), with a slightly significant heterogeneity among studies. However, heterogeneity disappeared when smokers were divided into current and ex-smokers. The risk of cancer was elevated in smokers and occupationally exposed subjects, with the highest risk among slow acetylators. The increase in risk was limited, in fact, to current smokers (odds ratio = 1.74, 95% confidence interval: 0.96-3.15). This analysis confirms that the NAT2 genotype is a risk factor for bladder cancer by interacting with smoking or occupational exposures. Our observation suggests that NAT2 is not a risk factors per se but modulates the effect of carcinogens contained in tobacco smoke (probably arylamines) or associated with occupational exposures.
Similar articles
-
Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.Cancer Epidemiol Biomarkers Prev. 1997 Apr;6(4):225-31. Cancer Epidemiol Biomarkers Prev. 1997. PMID: 9107426
-
XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk.Cancer Epidemiol Biomarkers Prev. 2002 Oct;11(10 Pt 1):1004-11. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12376500
-
N-acetyltransferase 2 and bladder cancer: an overview and consideration of the evidence for gene-environment interaction.Br J Cancer. 2000 Aug;83(3):412-7. doi: 10.1054/bjoc.2000.1265. Br J Cancer. 2000. PMID: 10917561 Free PMC article. Review.
-
Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):99-107. doi: 10.1158/1055-9965.EPI-05-0618. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16434594
-
A meta-analysis of the association of N-acetyltransferase 2 gene (NAT2) variants with breast cancer.Am J Epidemiol. 2007 Aug 1;166(3):246-54. doi: 10.1093/aje/kwm066. Epub 2007 May 29. Am J Epidemiol. 2007. PMID: 17535831 Review.
Cited by
-
[The causes of urinary bladder cancer and possibilities of prevention].Urologe A. 2006 Mar;45(3):361-7; quiz 368. doi: 10.1007/s00120-006-1018-6. Urologe A. 2006. PMID: 16514529 German.
-
N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk.Oncogene. 2006 Mar 13;25(11):1649-58. doi: 10.1038/sj.onc.1209374. Oncogene. 2006. PMID: 16550165 Free PMC article. Review.
-
NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.Lancet. 2005 Aug 20-26;366(9486):649-59. doi: 10.1016/S0140-6736(05)67137-1. Lancet. 2005. PMID: 16112301 Free PMC article.
-
Cohort profile: genomic data for 26 622 individuals from the Canadian Longitudinal Study on Aging (CLSA).BMJ Open. 2022 Mar 10;12(3):e059021. doi: 10.1136/bmjopen-2021-059021. BMJ Open. 2022. PMID: 35273064 Free PMC article.
-
Toxicological assessment of noxious inhalants.GMS Curr Top Otorhinolaryngol Head Neck Surg. 2004;3:Doc03. Epub 2004 Dec 28. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2004. PMID: 22073045 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical